NCT05987904View on ClinicalTrials.gov

Feasibility Study for Instant Cardiac Diagnostic and Post-operative Risk Assessment with the LynxPatch Device

CompletedOBSERVATIONAL
Enrollment

1,097

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
Cardiovascular DiseasesHeart Diseases
Interventions
DEVICE

LynxPatch

Measurements with the LynxPatch device are conducted.

Trial Locations (1)

44789

Med. Klinik II - Kardiologie und Angiologie, Bochum

Sponsors
All Listed Sponsors
collaborator

Meditrial Europe Ltd.

INDUSTRY

lead

Lynx Health Science GmbH

INDUSTRY

NCT05987904 - Feasibility Study for Instant Cardiac Diagnostic and Post-operative Risk Assessment with the LynxPatch Device | Biotech Hunter | Biotech Hunter